Post on 13-May-2015
What is this?
• Simple accurate means of Simple accurate means of measuring arterial waveforms from measuring arterial waveforms from a regular blood pressure cuff.a regular blood pressure cuff.
• Analyzes components of the arterial Analyzes components of the arterial pulse wavepulse wave
Arterial Pulse Wave
• Result of 2 processes:Result of 2 processes:
– Ejection wave from the heart (stroke Ejection wave from the heart (stroke volume)volume)
– Modification of wave as it is ejected Modification of wave as it is ejected into a somewhat non-compliant or stiff into a somewhat non-compliant or stiff arterial system (impedence/vascular arterial system (impedence/vascular resistance)resistance)
Analysis of the Vascular Wave
• In theory, can provide informationIn theory, can provide information
– Cardiac functionCardiac function
– State of the arterial systemState of the arterial system
• The analysis is complex and The analysis is complex and interrelated and the term interrelated and the term “ventriculo-vascular coupling” has “ventriculo-vascular coupling” has been introduced to describe this been introduced to describe this relationship.relationship.
How is it recorded?
• Use a regular blood pressure cuff Use a regular blood pressure cuff around the armaround the arm
• Sensor system in the boxSensor system in the box
• Analyze the oscillometric signalAnalyze the oscillometric signal
– Therefore, cuff position does not matterTherefore, cuff position does not matter
Sequence
• Record blood pressure normallyRecord blood pressure normally
• Cuff deflates for ≈ 5 secsCuff deflates for ≈ 5 secs
• Cuff is reinflated to 30 mmHg above Cuff is reinflated to 30 mmHg above systole (suprasystolic)systole (suprasystolic)
• Held for 12 secs (2 respiratory cycles)Held for 12 secs (2 respiratory cycles)
• Cuff deflatesCuff deflates
• Recording of suprasystolic signals is Recording of suprasystolic signals is analyzedanalyzed
• Means of multiple variablesMeans of multiple variables
Features of Suprasystolic Recording
• Subaudible signals (<20 Hertz)Subaudible signals (<20 Hertz)
– 95% of energy of pulse wave is <1 95% of energy of pulse wave is <1 HertzHertz
• Reproducible at 20-30 mmHg above Reproducible at 20-30 mmHg above systolic pressuresystolic pressure
Benefits Over Intra-arterial Measurements
• Not influenced by dampening secondary Not influenced by dampening secondary to air or thrombus in arterial lineto air or thrombus in arterial line
• Not influenced by kinking of catheterNot influenced by kinking of catheter
• Stable, reproducible signalsStable, reproducible signals
• Non-invasive, sterility issues, etc.Non-invasive, sterility issues, etc.
• No technical skill requiredNo technical skill required
Benefits over Tonometry at the Wrist (AtCor – Omron)
• More proximal signals (axillary vs. radial More proximal signals (axillary vs. radial artery)artery)
• Less technician dependentLess technician dependent
• Single measurement (Tonometry Single measurement (Tonometry measures BP separately)measures BP separately)
• Quicker and more simpleQuicker and more simple
• What can you measure?What can you measure?
• What do the waves mean?What do the waves mean?
Physiology
Distal aorta
Exit of heart
DirectDirect
Reflected
Pulse Wave
• Incident waveIncident wave
•Reflection waveReflection wave
Wave Reflections
Intra-arterial Tracing
Incident Incident wavewave
Aortic Aortic reflection reflection
wavewave
Late Late reflection reflection
wavewave
Dicrotic Dicrotic notchnotch
Intra-arterial tracing
Pulsecor suprasystolic waveform
Concurrent Signals
RWR = Reflection Wave Ratio (da/ab x 100)
PS1 = Suprasystolic pressure wave amplitude
dp/dt = Contractility (Peak change in slope of PS1)
RWTT = Reflected Wave Transit Time (a-c)
SEP = Systolic Ejection Period (a-e)
RWR (reflection wave ratio) = da/ab x 100
PS1
RWTT
a
b
c
d
e
ab
da
SEP
dp
/dt
What can waves tell you or be used for?
• Vascular screeningVascular screening
• Monitoring long term medical Monitoring long term medical therapy, e.g., antihypertensivetherapy, e.g., antihypertensive
• Monitoring acute physiological Monitoring acute physiological changes in critical care changes in critical care environmentenvironment
Vascular Screening
• RWR increases withRWR increases with
– AgeAge
– HypertensionHypertension
– Vascular stiffnessVascular stiffness
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
0
0.1
0.2
0.3
0.4
0.5
0.6
0
0.5
1
1.5
2
2.5
RWR = 17%
RWR = 65%
RWR = 325%
Baseline Reflection Wave Ratio vs. Age (n=200 hips)
R = 0.491
-1
0
1
2
3
4
5
6
7
8
9
30 40 50 60 70 80 90
RWR > 400% are over 70 years of age
Age
Baseline RWTT* vs. Age(n=200 hips)
*surrogate of pulse wave velocity
Age
.08
.1
.12
.14
.16
.18
.2
.22
.24
.26
.28
.3
30 40 50 60 70 80 90
R = 0.495
Arterial Stiffness vs. Brachial Blood Pressure
• Stronger predictor of cardiovascular disease and better guide to treatmentStronger predictor of cardiovascular disease and better guide to treatment• Stronger than other cardiovascular risk factorsStronger than other cardiovascular risk factors
Major Clinical Study OutcomeCAFE STUDY (Part of the Pfizer-
sponsored ASCOT study) - measured more than 2000 patients in the UK and Scandinavia, 2001-2006
Central blood pressure measurement showed big differences using two different drug regimens, clearly explaining different patient outcomes where brachial pressures showed no difference
USA NATIONAL INSTITUTE OF HEALTH’s STRONG HEART Study – measured more than 2400 patients for an average 4 years
Showed central pressures were strong predictors of cardiovascular outcomes, while brachial pressures were less predictive
REASON – Q: Does central pressure augmentation predict CV outcomes in renal failure patients?
Pressure augmentation was independently predictive of outcomes
ROTTERDAM - Q: Is arterial stiffness associated with risk of coronary heart disease and stroke?
Showed arterial stiffness is an independent predictor of coronary heart disease and stroke in asymptomatic individuals
Response to Medical Treatment: Effect of Stopping Losartan 50 mg/day
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
0.2
0.4
0.6
0.8
1
1.2
1.4Day 5 after stopping LosartanOn Losartan
• BP = 112/68 (80)BP = 112/68 (80) mmHgmmHg
• RWR = 33%RWR = 33%• dp/dt = 10 mmHg/secdp/dt = 10 mmHg/sec• PS1 = 0.6 mmHgPS1 = 0.6 mmHg
• BP = 144/85 (101) mmHgBP = 144/85 (101) mmHg
• RWR = 125%RWR = 125%• dp/dt = 15 mmHg/secdp/dt = 15 mmHg/sec• PS1 = 0.98 mmHgPS1 = 0.98 mmHg
CAFE Study
• Williams et al: Differential impact of Williams et al: Differential impact of blood pressure-lowering drugs on central blood pressure-lowering drugs on central aortic pressure and clinical outcomes: aortic pressure and clinical outcomes: principal results of the Conduit Artery principal results of the Conduit Artery Function Evaluation (CAFE) study. Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-25Circulation 2006; 113: 1213-25
Monitoring Acute Monitoring Acute Physiological Physiological ChangesChanges
Total Hip Replacement
• 200 patients on operating table200 patients on operating table
• Supine and awake prior to sedationSupine and awake prior to sedation
• Non-selectedNon-selected
– Many treated with ACE inhibitors etc.Many treated with ACE inhibitors etc.
Total Knee Replacement
• 44 patients44 patients
• Randomized to ephedrine versus Randomized to ephedrine versus phenylephrine under extensive phenylephrine under extensive epidural anesthesiaepidural anesthesia
Pulsecor Changes
PropofolPropofol VasodilatorVasodilator
PhenylephrinePhenylephrine VasoconstrictorVasoconstrictor
Phenyl + Extensive Phenyl + Extensive epidural anesthesiaepidural anesthesia Cardiac DepressionCardiac Depression
Ephedrine (inotropic Ephedrine (inotropic agent)agent) Cardiac StimulationCardiac Stimulation
FluidFluid
Effect of Propofol
• Sedative/anesthetic agentSedative/anesthetic agent
• Known arterial dilatorKnown arterial dilator
• Mild cardiac depressionMild cardiac depression
Effect of Propofol(n=200)
BaselineBaseline PropofolPropofol P ValueP Value
MAPMAP 100 ± 11100 ± 11 80 ± 1280 ± 12 <0.0001<0.0001
Pulse Pulse PressurePressure 60 ± 1260 ± 12 45 ± 845 ± 8 <0.0001<0.0001
RWR (%)RWR (%) 130 ± 110130 ± 110 70 ± 5070 ± 50 <0.0001<0.0001
RWTTRWTT 0.16 ± .030.16 ± .03 0.19 ± .030.19 ± .03 <0.0001<0.0001
dp/dtdp/dt 9.4 ± 4.49.4 ± 4.4 8.2 ± 3.88.2 ± 3.8 <0.0001<0.0001
PS1PS1 0.541 ± .270.541 ± .27 0.498 ± .240.498 ± .24 0.00070.0007
Effect of Propofol (vasodilator)
• BP = 136/84 (99) mmHgBP = 136/84 (99) mmHg• HR = 79 bpmHR = 79 bpm
• RWR = 111%RWR = 111%• dp/dt = 5.63 mmHg/secdp/dt = 5.63 mmHg/sec• PS1 = 0.31 mmHgPS1 = 0.31 mmHg
• BP = 113/66 (78) mmHgBP = 113/66 (78) mmHg• HR = 80 bpmHR = 80 bpm
• RWR = 59.5%RWR = 59.5%• dp/dt = 5.91 mmHg/secdp/dt = 5.91 mmHg/sec• PS1 = 0.34 mmHgPS1 = 0.34 mmHg
0
0.1
0.2
0.3
0.4
0
0.1
0.2
0.3
0.4
Effect of Intravenous Phenylephrine
• VasoconstrictionVasoconstriction
Vasoconstriction(TKR; n=22)
PropofolPropofol EA* + EA* + PhenylPhenyl P ValueP Value
MAPMAP 76 ± 876 ± 8 84 ± 884 ± 8 <0.0001<0.0001
HRHR 77 ± 1077 ± 10 59 ± 959 ± 9 <0.0001<0.0001
RWRRWR 56 ± 3056 ± 30 149 ± 69149 ± 69 <0.0001<0.0001
RWTTRWTT 0.193 ± .020.193 ± .02 0.178 ± .030.178 ± .03 =0.0378=0.0378
*EA = Epidural anesthesia
Effect of Phenylephrine (vasoconstrictor)
• BP = 115/70 (82) mmHgBP = 115/70 (82) mmHg• HR = 76 bpmHR = 76 bpm
• RWR = 42%RWR = 42%
• BP = 117/71 (84) BP = 117/71 (84) mmHgmmHg
• HR = 63 bpmHR = 63 bpm
• RWR = 212%RWR = 212%
0
0.1
0.2
0.3
0.4
0.5
0.6
0
0.1
0.2
0.3
0.4
0.5
0.6
Hand in Ice
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
0.2
0.4
0.6
0.8
1
1.2
1.4
• BP = 122/64 (81) mmHgBP = 122/64 (81) mmHg• HR = 61 bpmHR = 61 bpm
• RWR = 40.7%RWR = 40.7%• dp/dt = 17.6 mmHg/secdp/dt = 17.6 mmHg/sec• PS1 = 1.05 mmHgPS1 = 1.05 mmHg
• BP = 152/88 (103) mmHgBP = 152/88 (103) mmHg• HR = 75 bpmHR = 75 bpm
• RWR = 74.7%RWR = 74.7%• dp/dt = 19.96 mmHg/secdp/dt = 19.96 mmHg/sec• PS1 = 1.2 mmHgPS1 = 1.2 mmHg
Cardiac Depression (Clinical model)
• Extensive epidural Extensive epidural autonomic autonomic blockade of the heartblockade of the heart
• Vasoconstriction Vasoconstriction no cardiac no cardiac stimulationstimulation
Cardiac Depression (TKR; n=22)
PropofolPropofol EA* + EA* + PhenylPhenyl P ValueP Value
MAPMAP 76 ± 876 ± 8 84 ± 884 ± 8 <0.0001<0.0001
Pulse Pulse PressurePressure 46 ± 946 ± 9 48 ± 848 ± 8 NSNS
HRHR 77 ± 1077 ± 10 60 ± 960 ± 9 <0.0001<0.0001
dp/dtdp/dt 8.6 ± 2.78.6 ± 2.7 5.4 ± 25.4 ± 2 <0.0001<0.0001
PS1PS1 0.52 ± 0.52 ± 0.170.17 0.35 ± 0.140.35 ± 0.14 <0.0001<0.0001
*EA = Epidural anesthesia
Effect of Phenylephrine + Extensive Epidural Anesthesia (Cardiac depression)
• BP = 115/70 (82) mmHgBP = 115/70 (82) mmHg• HR = 76 bpmHR = 76 bpm
• RWR = 42%RWR = 42%• PS1 = 0.58 mmHgPS1 = 0.58 mmHg• dp/dt = 11 mmHg/secdp/dt = 11 mmHg/sec
• BP = 117/71 (84) BP = 117/71 (84) mmHgmmHg
• HR = 63 bpmHR = 63 bpm
• RWR = 212%RWR = 212%• PS1 = 0.23 mmHgPS1 = 0.23 mmHg• dp/dt = 3.62 mmHg/secdp/dt = 3.62 mmHg/sec
0
0.1
0.2
0.3
0.4
0.5
0.6
0
0.1
0.2
0.3
0.4
0.5
0.6
Ephedrine
• Cardiac stimulantCardiac stimulant
Effect of Ephedrine(n=109)
Post FluidPost Fluid Post Post EphedrineEphedrine P ValueP Value
MAPMAP 47 ± 747 ± 7 63 ± 1063 ± 10 <0.0001<0.0001
Pulse Pulse PressurePressure 38 ± 7.638 ± 7.6 46 ± 7.846 ± 7.8 <0.0001<0.0001
RWR (%)RWR (%) 29.5 ± 1829.5 ± 18 24.4 ± 2024.4 ± 20 0.0050.005
RWTTRWTT 0.241 0.241 ± .03± .03 0.228 ± .030.228 ± .03 0.00020.0002
dp/dtdp/dt 6.2 ± 2.46.2 ± 2.4 9.4 ± 3.89.4 ± 3.8 <0.0001<0.0001
PS1PS1 0.43 ± .160.43 ± .16 0.62 ± .240.62 ± .24 <0.0001<0.0001
Effect of Ephedrine(cardiac stimulant / inotrope)
• BP = 68/30 (40) mmHgBP = 68/30 (40) mmHg• HR = 57 bpmHR = 57 bpm
• RWR = 20%RWR = 20%• dp/dt = 4.72 mmHg/secdp/dt = 4.72 mmHg/sec• PS1 = 0.36 mmHgPS1 = 0.36 mmHg
• BP = 94/45 (58) mmHgBP = 94/45 (58) mmHg• HR = 64 bpmHR = 64 bpm
• RWR = 14%RWR = 14%• dp/dt = 8.6 mmHg/secdp/dt = 8.6 mmHg/sec• PS1 = 0.66 mmHgPS1 = 0.66 mmHg
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Effect of Exercise(15 min stationary bike, HR ≈130 bpm)
• BP = 129/70 (87) mmHgBP = 129/70 (87) mmHg• HR = 65 bpmHR = 65 bpm
• RWR = 44%RWR = 44%• dp/dt = 11.75 mmHg/secdp/dt = 11.75 mmHg/sec• PS1 = 0.66 mmHgPS1 = 0.66 mmHg
• BP = 164/72 (97) mmHgBP = 164/72 (97) mmHg• HR = 134 bpmHR = 134 bpm
• RWR = 6.2%RWR = 6.2%• dp/dt = 24.6 mmHg/secdp/dt = 24.6 mmHg/sec• PS1 = 1.01 mmHgPS1 = 1.01 mmHg
0
0.2
0.4
0.6
0.8
1
1.2
0
0.2
0.4
0.6
0.8
1
1.2
Effect of Low Dose Epinephrine
• Low dose Low dose 3 µg/min 3 µg/min
• Increase stroke volumeIncrease stroke volume
• Decrease arterial toneDecrease arterial tone
Effect of Low Dose Epinephrine
• BP = 91/56 (66) mmHgBP = 91/56 (66) mmHg• HR = 57 bpmHR = 57 bpm
• RWR = 41%RWR = 41%• dp/dt = 7.94 mmHg/secdp/dt = 7.94 mmHg/sec• RWTT = 0.22 sec.RWTT = 0.22 sec.• PS1 = 0.64 mmHgPS1 = 0.64 mmHg
Epinephrine (3 Epinephrine (3 µg/min)µg/min)
No EpinephrineNo Epinephrine
• BP = 109/73 (83) mmHgBP = 109/73 (83) mmHg• HR = 49 bpmHR = 49 bpm
• RWR = 118%RWR = 118%• dp/dt = 7.81 mmHg/secdp/dt = 7.81 mmHg/sec• RWTT = 0.17 sec.RWTT = 0.17 sec.• PS1 = 0.46 mmHgPS1 = 0.46 mmHg
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Effect of Fluid(n=109)CVP increased 4 mmHg (mean)
Pre FluidPre Fluid Post FluidPost Fluid P ValueP Value
MAPMAP 43 ± 643 ± 6 47 ± 747 ± 7 <0.0001<0.0001
Pulse Pulse PressurePressure 36 ± 736 ± 7 38 ± 7.638 ± 7.6 <0.0001<0.0001
RWR (%)RWR (%) 31 ± 1931 ± 19 29 ± 1829 ± 18 NSNS
RWTTRWTT 0.242 ± .040.242 ± .04 0.241 ± .030.241 ± .03 NSNS
dp/dtdp/dt 5.2 ± 25.2 ± 2 6.2 ± 2.46.2 ± 2.4 <0.0001<0.0001
PS1PS1 0.344 ± .120.344 ± .12 0.431 ± .160.431 ± .16 <0.0001<0.0001
Effect of Snoring
Snoring
dPP = 122%
Snoring Eliminated
dPP = 59%
Atrial Fibrillation